131 related articles for article (PubMed ID: 3859364)
1. Cytotoxicity of monoclonal antibodies against individually immunophenotyped human leukemic cells.
Beksac M; Porwit-Ksiazek A; Hast R; Biberfeld P; Reizenstein P
Cancer Immunol Immunother; 1985; 19(3):231-6. PubMed ID: 3859364
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the individual and combined reactivities of monoclonal antibodies H25, H366, and MY9 with normal progenitor cells and blast cells from patients with acute myeloblastic leukemia.
Wisniewski D; Strife A; Arlin Z; Knowles R; Lambek C; Gulati S; McHendry B; McKenzie S; Clarkson B
Leukemia; 1989 Jun; 3(6):446-52. PubMed ID: 2657231
[TBL] [Abstract][Full Text] [Related]
3. A bispecific antibody enhances cytokine-induced killer-mediated cytolysis of autologous acute myeloid leukemia cells.
Kaneko T; Fusauchi Y; Kakui Y; Masuda M; Akahoshi M; Teramura M; Motoji T; Okumura K; Mizoguchi H; Oshimi K
Blood; 1993 Mar; 81(5):1333-41. PubMed ID: 8095165
[TBL] [Abstract][Full Text] [Related]
4. Autologous bone marrow transplantation in acute myelogenous leukemia: in vitro treatment with myeloid-specific monoclonal antibodies and drugs in combination.
Lemoli RM; Gasparetto C; Scheinberg DA; Moore MA; Clarkson BD; Gulati SC
Blood; 1991 Apr; 77(8):1829-36. PubMed ID: 2015406
[TBL] [Abstract][Full Text] [Related]
5. Studies on the ability of monoclonal antibodies to selectively mediate complement-dependent cytotoxicity of human myelogenous leukemia blast cells.
Ball ED; Kadushin JM; Schacter B; Fanger MW
J Immunol; 1982 Mar; 128(3):1476-81. PubMed ID: 6948897
[TBL] [Abstract][Full Text] [Related]
6. Immunophenotyping of acute myeloid leukemia using monoclonal antibodies and the alkaline phosphatase-antialkaline phosphatase technique.
Hanson CA; Gajl-Peczalska KJ; Parkin JL; Brunning RD
Blood; 1987 Jul; 70(1):83-9. PubMed ID: 3297208
[TBL] [Abstract][Full Text] [Related]
7. Reactivity profiles of leukemic myeloblasts with monoclonal antibodies directed to sialosyl-Le(x) and other lacto-series type 2 chain antigens:absence of reactivity with normal hematopoietic progenitor cells.
Muroi K; Suda T; Nojiri H; Ema H; Amemiya Y; Miura Y; Nakauchi H; Singhal A; Hakomori S
Blood; 1992 Feb; 79(3):713-9. PubMed ID: 1370643
[TBL] [Abstract][Full Text] [Related]
8. Initial trial of bispecific antibody-mediated immunotherapy of CD15-bearing tumors: cytotoxicity of human tumor cells using a bispecific antibody comprised of anti-CD15 (MoAb PM81) and anti-CD64/Fc gamma RI (MoAb 32).
Ball ED; Guyre PM; Mills L; Fisher J; Dinces NB; Fanger MW
J Hematother; 1992; 1(1):85-94. PubMed ID: 1365020
[TBL] [Abstract][Full Text] [Related]
9. Lysis of fresh leukemic blasts by interferon-activated human natural killer cells.
Pattengale PK; Sundstrom C; Yu AL; Levine A
Nat Immun Cell Growth Regul; 1983-1984; 3(4):165-80. PubMed ID: 6597341
[TBL] [Abstract][Full Text] [Related]
10. An antigen shared by human granulocytes, monocytes, marrow granulocyte precursors and leukemic blasts.
Shumak KH; Rachkewich RA
Acta Haematol; 1983; 69(3):164-70. PubMed ID: 6404099
[TBL] [Abstract][Full Text] [Related]
11. Lactate dehydrogenase-release assay: a reliable, nonradioactive technique for analysis of cytotoxic lymphocyte-mediated lytic activity against blasts from acute myelocytic leukemia.
Weidmann E; Brieger J; Jahn B; Hoelzer D; Bergmann L; Mitrou PS
Ann Hematol; 1995 Mar; 70(3):153-8. PubMed ID: 7718644
[TBL] [Abstract][Full Text] [Related]
12. Antigenic determinants on myeloid leukaemia colony-forming cells resemble those of normal myeloid progenitor cells and differ from those of circulating blast cells.
Robak T; Dowding C; Garewal G; Hibbin JA; Th'ng KH; Goldman JM
Br J Haematol; 1986 Sep; 64(1):133-48. PubMed ID: 2428394
[TBL] [Abstract][Full Text] [Related]
13. Effects of anti-myeloid antibodies on the generation of hematopoietic colony-forming units in long-term bone marrow culture.
Ball ED; Keefe KA; McDermott JM
Bone Marrow Transplant; 1989 May; 4(3):309-15. PubMed ID: 2659116
[TBL] [Abstract][Full Text] [Related]
14. "Pan-myeloid" reagent: the monoclonal antibody MCS-2 in the routine immunodiagnostic service of leukemia phenotyping.
Drexler HG; Sagawa K; Menon M; Minowada J
Jpn J Cancer Res; 1985 Mar; 76(3):235-9. PubMed ID: 3922842
[TBL] [Abstract][Full Text] [Related]
15. Autologous bone marrow transplantation in acute myelogenous leukemia: in vitro treatment with myeloid cell-specific monoclonal antibodies.
Ball ED; Mills LE; Coughlin CT; Beck JR; Cornwell GG
Blood; 1986 Dec; 68(6):1311-5. PubMed ID: 3535927
[TBL] [Abstract][Full Text] [Related]
16. Normal and malignant human myelocytic and monocytic cells identified by monoclonal antibodies.
Bernstein ID; Andrews RG; Cohen SF; McMaster BE
J Immunol; 1982 Feb; 128(2):876-81. PubMed ID: 6948042
[TBL] [Abstract][Full Text] [Related]
17. The expression of myeloid-specific antigens on myeloid leukemia cells: correlations with leukemia subclasses and implications for normal myeloid differentiation.
Ball ED; Fanger MW
Blood; 1983 Mar; 61(3):456-63. PubMed ID: 6186318
[TBL] [Abstract][Full Text] [Related]
18. Specificity of heteroantisera to human acute leukemia-associated antigens.
Baker MA; Ramachandar K; Taub RN
J Clin Invest; 1974 Dec; 54(6):1273-8. PubMed ID: 4140196
[TBL] [Abstract][Full Text] [Related]
19. A unique antigen expressed on myeloid cells and acute leukemia blast cells defined by a monoclonal antibody.
Ball ED; Graziano RF; Fanger MW
J Immunol; 1983 Jun; 130(6):2937-41. PubMed ID: 6574189
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibody-mediated cytotoxicity of human myeloid leukemia cells: an in vitro model for estimating efficiency and optimal conditions for cytolysis.
Howell AL; Ball ED
Blood; 1985 Sep; 66(3):649-54. PubMed ID: 3861203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
